FIELD: organic chemistry.
SUBSTANCE: group of inventions relates to organic chemistry and represents methods for producing a form B of 3-[5-amino-4-(3-cyanobenzoyl)pyrazole-1-yl]-N-cyclopropyl-4-methylbenzamide having a powder X-ray diffraction pattern measured using Cu Kα radiation with peaks at 2θ approximately = 9.6, 10.1, 11.4, 13.1, 13.9, 14.8, 15.4, 15.8, 17.0, 17.4, 18.5, 18.8, 19.7, 19.9, 20.5, 21.0, 21.9, 22.9, 23.6, 24.6 and 25.7°. Methods are carried out by dissolving 3-[5-amino-4-(3-cyanobenzoyl)pyrazole-1-yl]-N-cyclopropyl-4-methylbenzamide at a temperature of at least 75°C in a solvent or a mixture of solvents selected from a group consisting of C1-6 alcohols or mixtures thereof and containing less than approximately 5% by weight of water relatively to initial substance. The resulting solution is cooled at a temperature not exceeding 40°C. Then, isolated crystals are heated at a temperature from 75 to 210°C for more than 1 min, obtaining the form B of 3-[5-amino-4-(3-cyanobenzoyl)pyrazole-1-yl]-N-cyclopropyl-4-methylbenzamide. An alternative method for the production includes: dissolution of 3-[5-amino-4-(3-cyanobenzoyl)pyrazole-1-yl]-N-cyclopropyl-4-methylbenzamide at a temperature of 105°C in an anhydrous solvent or a mixture of anhydrous solvents selected from a group consisting of C1-6 alcohols or mixtures thereof; optional filtration of the resulting solution to remove particles with a maximum diameter of more than 100 mcm; cooling of the solution to 85°C; introduction of a seed in a solution of crystals of the form B of 3-[5-amino-4-(3-cyanobenzoyl)pyrazole-1-yl]-N-cyclopropyl-4-methylbenzamide; optional additional cooling of the solution; optional addition of a seed to the solution of crystals of the form B of 3-[5-amino-4-(3-cyanobenzoyl)pyrazole-1-yl]-N-cyclopropyl-4-methylbenzamide; cooling of the solution to less than 70°C and isolation of crystals of the form B of 3-[5-amino-4-(3-cyanobenzoyl)pyrazole-1-yl]-N-cyclopropyl-4-methylbenzamide.
EFFECT: methods make it possible to obtain a crystalline modification of 3-[5-amino-4-(3-cyanobenzoyl)pyrazole-1-yl]-N-cyclopropyl-4-methylbenzamide, which has a combination of several properties, namely improved hygroscopicity, thermodynamic stability and solubility.
32 cl, 9 dwg, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)PYRAZOLE-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE | 2017 |
|
RU2792728C2 |
DOSING REGIMEN FOR TREATING ACUTE EXACERBATIONS OF INFLAMMATORY CONDITIONS | 2016 |
|
RU2709509C1 |
DOSING REGIMEN FOR TREATING ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2713203C1 |
APPLICATION OF PYRAZOLE DERIVATIVE IN TREATMENT OF ACUTE ATTACKS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2013 |
|
RU2625762C2 |
DERIVATIVES OF 5-MEMBER HETEROCYCLES AS KINASE p38 INHIBITORS | 2004 |
|
RU2381219C2 |
MANUFACTURE OF 2-(5-BROMO-4(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID | 2013 |
|
RU2666549C2 |
MALIC ACID SALTS AND (3S,5S)-7-[3-AMINO-5-METHYLPIPERIDINYL]-1-CYCLOPROPYL-1,4-DIHYDRO-8-METHOXY-4-OXO-3-CHINOLINE CARBOXYLIC ACID POLYMORPHS | 2007 |
|
RU2417222C2 |
CRYSTALLINE FORMS OF BTK INHIBITOR | 2020 |
|
RU2828460C2 |
METHOD FOR PRODUCING 4-AMINO-5-FLUORO-3-HALOGEN-6- (SUBSTITUTED) PYCOLINATES | 2013 |
|
RU2632203C2 |
ANTITUMOR AGENT AND BROMODOMAIN INHIBITOR | 2017 |
|
RU2752163C2 |
Authors
Dates
2022-02-02—Published
2017-07-13—Filed